drugset / Trial / NCT00387504

Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

NCT00387504

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as fenretinide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I trial is studying the side effects and best dose of fenretinide in treating patients with metastatic or unresectable malignant solid tumors.

Timeline

Start
2006-11
Primary completion
2013-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject fenretinide Small molecule Intravenous